GO:0003674 | molecular_function | 72.83% (134/184) | 0.48 | 0.0 | 6e-06 |
GO:0005488 | binding | 50.0% (92/184) | 0.66 | 0.0 | 5.9e-05 |
GO:0006139 | nucleobase-containing compound metabolic process | 15.22% (28/184) | 1.49 | 1e-06 | 0.000182 |
GO:0016874 | ligase activity | 4.89% (9/184) | 3.0 | 2e-06 | 0.0004 |
GO:0044281 | small molecule metabolic process | 9.78% (18/184) | 1.76 | 7e-06 | 0.000507 |
GO:0035639 | purine ribonucleoside triphosphate binding | 17.93% (33/184) | 1.21 | 5e-06 | 0.000509 |
GO:0034660 | ncRNA metabolic process | 4.89% (9/184) | 2.8 | 7e-06 | 0.000532 |
GO:0046483 | heterocycle metabolic process | 15.22% (28/184) | 1.37 | 4e-06 | 0.00055 |
GO:0006725 | cellular aromatic compound metabolic process | 15.22% (28/184) | 1.35 | 5e-06 | 0.00056 |
GO:1901360 | organic cyclic compound metabolic process | 15.22% (28/184) | 1.33 | 7e-06 | 0.000599 |
GO:0032555 | purine ribonucleotide binding | 17.93% (33/184) | 1.15 | 1.2e-05 | 0.0008 |
GO:0003755 | peptidyl-prolyl cis-trans isomerase activity | 2.72% (5/184) | 3.84 | 2.8e-05 | 0.000813 |
GO:0006082 | organic acid metabolic process | 7.07% (13/184) | 2.0 | 2.6e-05 | 0.000814 |
GO:0043436 | oxoacid metabolic process | 7.07% (13/184) | 2.0 | 2.6e-05 | 0.000838 |
GO:0000038 | very long-chain fatty acid metabolic process | 1.09% (2/184) | 7.75 | 2.2e-05 | 0.00085 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 1.09% (2/184) | 7.75 | 2.2e-05 | 0.00085 |
GO:0019001 | guanyl nucleotide binding | 4.89% (9/184) | 2.58 | 2.3e-05 | 0.000853 |
GO:0034641 | cellular nitrogen compound metabolic process | 16.3% (30/184) | 1.17 | 2.6e-05 | 0.000876 |
GO:0016859 | cis-trans isomerase activity | 2.72% (5/184) | 3.8 | 3.1e-05 | 0.000887 |
GO:0032553 | ribonucleotide binding | 17.93% (33/184) | 1.13 | 1.5e-05 | 0.000893 |
GO:0097159 | organic cyclic compound binding | 32.07% (59/184) | 0.75 | 1.6e-05 | 0.000895 |
GO:0097367 | carbohydrate derivative binding | 17.93% (33/184) | 1.12 | 1.8e-05 | 0.000901 |
GO:0019752 | carboxylic acid metabolic process | 7.07% (13/184) | 2.01 | 2.6e-05 | 0.000908 |
GO:0032561 | guanyl ribonucleotide binding | 4.89% (9/184) | 2.6 | 2.1e-05 | 0.000919 |
GO:0005525 | GTP binding | 4.89% (9/184) | 2.6 | 2.1e-05 | 0.000919 |
GO:0017076 | purine nucleotide binding | 17.93% (33/184) | 1.07 | 3.7e-05 | 0.001007 |
GO:0000166 | nucleotide binding | 18.48% (34/184) | 1.04 | 4.3e-05 | 0.001041 |
GO:1901265 | nucleoside phosphate binding | 18.48% (34/184) | 1.04 | 4.3e-05 | 0.001041 |
GO:0044237 | cellular metabolic process | 26.63% (49/184) | 0.81 | 4e-05 | 0.001055 |
GO:0043168 | anion binding | 18.48% (34/184) | 1.03 | 5e-05 | 0.00119 |
GO:0090304 | nucleic acid metabolic process | 11.41% (21/184) | 1.38 | 6.1e-05 | 0.001404 |
GO:0009987 | cellular process | 36.41% (67/184) | 0.62 | 7e-05 | 0.001547 |
GO:0006807 | nitrogen compound metabolic process | 27.17% (50/184) | 0.76 | 7.8e-05 | 0.001676 |
GO:0000049 | tRNA binding | 1.63% (3/184) | 5.08 | 9.1e-05 | 0.001848 |
GO:0016070 | RNA metabolic process | 8.15% (15/184) | 1.67 | 8.9e-05 | 0.00186 |
GO:0016853 | isomerase activity | 4.35% (8/184) | 2.5 | 9.5e-05 | 0.001875 |
GO:1901363 | heterocyclic compound binding | 18.48% (34/184) | 0.98 | 0.0001 | 0.001913 |
GO:0036094 | small molecule binding | 18.48% (34/184) | 0.96 | 0.000119 | 0.002222 |
GO:0006399 | tRNA metabolic process | 3.26% (6/184) | 2.96 | 0.00013 | 0.002372 |
GO:0003676 | nucleic acid binding | 17.39% (32/184) | 0.94 | 0.000259 | 0.004594 |
GO:0003924 | GTPase activity | 3.8% (7/184) | 2.47 | 0.000298 | 0.005154 |
GO:0140101 | catalytic activity, acting on a tRNA | 2.72% (5/184) | 3.08 | 0.000334 | 0.005502 |
GO:0003723 | RNA binding | 7.61% (14/184) | 1.56 | 0.000332 | 0.005596 |
GO:0007094 | mitotic spindle assembly checkpoint signaling | 1.09% (2/184) | 5.75 | 0.000593 | 0.007253 |
GO:0033046 | negative regulation of sister chromatid segregation | 1.09% (2/184) | 5.75 | 0.000593 | 0.007253 |
GO:0031577 | spindle checkpoint signaling | 1.09% (2/184) | 5.75 | 0.000593 | 0.007253 |
GO:1905819 | negative regulation of chromosome separation | 1.09% (2/184) | 5.75 | 0.000593 | 0.007253 |
GO:0071173 | spindle assembly checkpoint signaling | 1.09% (2/184) | 5.75 | 0.000593 | 0.007253 |
GO:0071174 | mitotic spindle checkpoint signaling | 1.09% (2/184) | 5.75 | 0.000593 | 0.007253 |
GO:0051985 | negative regulation of chromosome segregation | 1.09% (2/184) | 5.75 | 0.000593 | 0.007253 |
GO:0051784 | negative regulation of nuclear division | 1.09% (2/184) | 5.75 | 0.000593 | 0.007253 |
GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 1.09% (2/184) | 5.75 | 0.000593 | 0.007253 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 1.09% (2/184) | 5.75 | 0.000593 | 0.007253 |
GO:0045839 | negative regulation of mitotic nuclear division | 1.09% (2/184) | 5.75 | 0.000593 | 0.007253 |
GO:0033048 | negative regulation of mitotic sister chromatid segregation | 1.09% (2/184) | 5.75 | 0.000593 | 0.007253 |
GO:2000816 | negative regulation of mitotic sister chromatid separation | 1.09% (2/184) | 5.75 | 0.000593 | 0.007253 |
GO:0006520 | amino acid metabolic process | 4.35% (8/184) | 2.16 | 0.000478 | 0.007705 |
GO:0005515 | protein binding | 19.57% (36/184) | 0.8 | 0.000678 | 0.008153 |
GO:0003824 | catalytic activity | 38.59% (71/184) | 0.5 | 0.000568 | 0.008948 |
GO:2001251 | negative regulation of chromosome organization | 1.09% (2/184) | 5.58 | 0.00076 | 0.008986 |
GO:0007088 | regulation of mitotic nuclear division | 1.09% (2/184) | 5.42 | 0.000948 | 0.009464 |
GO:0033047 | regulation of mitotic sister chromatid segregation | 1.09% (2/184) | 5.42 | 0.000948 | 0.009464 |
GO:0010965 | regulation of mitotic sister chromatid separation | 1.09% (2/184) | 5.42 | 0.000948 | 0.009464 |
GO:1905818 | regulation of chromosome separation | 1.09% (2/184) | 5.42 | 0.000948 | 0.009464 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 1.09% (2/184) | 5.42 | 0.000948 | 0.009464 |
GO:0006418 | tRNA aminoacylation for protein translation | 2.17% (4/184) | 3.27 | 0.000817 | 0.0095 |
GO:0004812 | aminoacyl-tRNA ligase activity | 2.17% (4/184) | 3.24 | 0.000888 | 0.009542 |
GO:0043038 | amino acid activation | 2.17% (4/184) | 3.24 | 0.000888 | 0.009542 |
GO:0043039 | tRNA aminoacylation | 2.17% (4/184) | 3.24 | 0.000888 | 0.009542 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 2.17% (4/184) | 3.24 | 0.000888 | 0.009542 |
GO:0044238 | primary metabolic process | 28.8% (53/184) | 0.6 | 0.000836 | 0.00956 |
GO:0046451 | diaminopimelate metabolic process | 1.09% (2/184) | 5.29 | 0.001155 | 0.010633 |
GO:0006553 | lysine metabolic process | 1.09% (2/184) | 5.29 | 0.001155 | 0.010633 |
GO:0009089 | lysine biosynthetic process via diaminopimelate | 1.09% (2/184) | 5.29 | 0.001155 | 0.010633 |
GO:0045930 | negative regulation of mitotic cell cycle | 1.09% (2/184) | 5.29 | 0.001155 | 0.010633 |
GO:0009085 | lysine biosynthetic process | 1.09% (2/184) | 5.29 | 0.001155 | 0.010633 |
GO:0007093 | mitotic cell cycle checkpoint signaling | 1.09% (2/184) | 5.29 | 0.001155 | 0.010633 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 5.43% (10/184) | 1.69 | 0.001196 | 0.010875 |
GO:0043648 | dicarboxylic acid metabolic process | 1.63% (3/184) | 3.84 | 0.001222 | 0.010968 |
GO:0051129 | negative regulation of cellular component organization | 1.09% (2/184) | 5.16 | 0.001381 | 0.012092 |
GO:0010639 | negative regulation of organelle organization | 1.09% (2/184) | 5.16 | 0.001381 | 0.012092 |
GO:0009451 | RNA modification | 2.72% (5/184) | 2.58 | 0.001565 | 0.01353 |
GO:0034470 | ncRNA processing | 2.72% (5/184) | 2.57 | 0.001643 | 0.014035 |
GO:0051783 | regulation of nuclear division | 1.09% (2/184) | 4.94 | 0.001893 | 0.015607 |
GO:0005829 | cytosol | 1.09% (2/184) | 4.94 | 0.001893 | 0.015607 |
GO:0030154 | cell differentiation | 1.09% (2/184) | 4.94 | 0.001893 | 0.015607 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3.8% (7/184) | 2.0 | 0.001979 | 0.016128 |
GO:0005524 | ATP binding | 13.04% (24/184) | 0.91 | 0.002189 | 0.016508 |
GO:0008152 | metabolic process | 30.98% (57/184) | 0.51 | 0.002188 | 0.016681 |
GO:0000075 | cell cycle checkpoint signaling | 1.09% (2/184) | 4.84 | 0.002178 | 0.016782 |
GO:1901988 | negative regulation of cell cycle phase transition | 1.09% (2/184) | 4.84 | 0.002178 | 0.016782 |
GO:0010948 | negative regulation of cell cycle process | 1.09% (2/184) | 4.84 | 0.002178 | 0.016782 |
GO:0016462 | pyrophosphatase activity | 5.43% (10/184) | 1.58 | 0.002098 | 0.016907 |
GO:0043167 | ion binding | 21.74% (40/184) | 0.66 | 0.002138 | 0.017034 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 5.43% (10/184) | 1.55 | 0.002388 | 0.01782 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 5.43% (10/184) | 1.54 | 0.002556 | 0.018879 |
GO:0046394 | carboxylic acid biosynthetic process | 3.26% (6/184) | 2.11 | 0.002842 | 0.019564 |
GO:0016053 | organic acid biosynthetic process | 3.26% (6/184) | 2.11 | 0.002842 | 0.019564 |
GO:0003684 | damaged DNA binding | 1.09% (2/184) | 4.66 | 0.002803 | 0.019679 |
GO:0033045 | regulation of sister chromatid segregation | 1.09% (2/184) | 4.66 | 0.002803 | 0.019679 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1.09% (2/184) | 4.66 | 0.002803 | 0.019679 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 1.09% (2/184) | 4.66 | 0.002803 | 0.019679 |
GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor | 1.09% (2/184) | 4.66 | 0.002803 | 0.019679 |
GO:0033044 | regulation of chromosome organization | 1.09% (2/184) | 4.58 | 0.003144 | 0.021434 |
GO:0043170 | macromolecule metabolic process | 21.74% (40/184) | 0.62 | 0.003315 | 0.022384 |
GO:0008641 | ubiquitin-like modifier activating enzyme activity | 1.09% (2/184) | 4.5 | 0.003503 | 0.023213 |
GO:0051983 | regulation of chromosome segregation | 1.09% (2/184) | 4.5 | 0.003503 | 0.023213 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 1.09% (2/184) | 4.42 | 0.003881 | 0.025242 |
GO:0140098 | catalytic activity, acting on RNA | 3.8% (7/184) | 1.83 | 0.003847 | 0.025254 |
GO:0032559 | adenyl ribonucleotide binding | 13.04% (24/184) | 0.84 | 0.00405 | 0.025867 |
GO:0071704 | organic substance metabolic process | 28.8% (53/184) | 0.5 | 0.004016 | 0.025885 |
GO:0007346 | regulation of mitotic cell cycle | 1.09% (2/184) | 4.35 | 0.004276 | 0.027069 |
GO:0016925 | protein sumoylation | 0.54% (1/184) | 7.75 | 0.004658 | 0.02823 |
GO:0019948 | SUMO activating enzyme activity | 0.54% (1/184) | 7.75 | 0.004658 | 0.02823 |
GO:0001731 | formation of translation preinitiation complex | 0.54% (1/184) | 7.75 | 0.004658 | 0.02823 |
GO:0033971 | hydroxyisourate hydrolase activity | 0.54% (1/184) | 7.75 | 0.004658 | 0.02823 |
GO:0034457 | Mpp10 complex | 0.54% (1/184) | 7.75 | 0.004658 | 0.02823 |
GO:0045786 | negative regulation of cell cycle | 1.09% (2/184) | 4.22 | 0.00512 | 0.030506 |
GO:0009259 | ribonucleotide metabolic process | 2.72% (5/184) | 2.19 | 0.005115 | 0.030735 |
GO:0019693 | ribose phosphate metabolic process | 2.72% (5/184) | 2.17 | 0.005391 | 0.031855 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 1.63% (3/184) | 3.05 | 0.005857 | 0.034316 |
GO:1901987 | regulation of cell cycle phase transition | 1.09% (2/184) | 4.1 | 0.006035 | 0.035069 |
GO:0004674 | protein serine/threonine kinase activity | 2.17% (4/184) | 2.45 | 0.006387 | 0.036816 |
GO:0009112 | nucleobase metabolic process | 1.09% (2/184) | 4.05 | 0.006517 | 0.037265 |
GO:0009982 | pseudouridine synthase activity | 1.09% (2/184) | 3.99 | 0.007017 | 0.039803 |
GO:0016877 | ligase activity, forming carbon-sulfur bonds | 1.09% (2/184) | 3.94 | 0.007534 | 0.042395 |
GO:0035065 | regulation of histone acetylation | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0003876 | AMP deaminase activity | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0031499 | TRAMP complex | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0070985 | transcription factor TFIIK complex | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0032264 | IMP salvage | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0008840 | 4-hydroxy-tetrahydrodipicolinate synthase activity | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0032261 | purine nucleotide salvage | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0004819 | glutamine-tRNA ligase activity | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0006425 | glutaminyl-tRNA aminoacylation | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0008353 | RNA polymerase II CTD heptapeptide repeat kinase activity | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0008568 | microtubule severing ATPase activity | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0031056 | regulation of histone modification | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0140776 | protein-containing complex destabilizing activity | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0047623 | adenosine-phosphate deaminase activity | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:2000756 | regulation of peptidyl-lysine acetylation | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:1901983 | regulation of protein acetylation | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0106380 | purine ribonucleotide salvage | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0031119 | tRNA pseudouridine synthesis | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0004163 | diphosphomevalonate decarboxylase activity | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:0008836 | diaminopimelate decarboxylase activity | 0.54% (1/184) | 6.75 | 0.009295 | 0.043358 |
GO:1901135 | carbohydrate derivative metabolic process | 3.26% (6/184) | 1.74 | 0.009623 | 0.044594 |
GO:0030554 | adenyl nucleotide binding | 13.04% (24/184) | 0.76 | 0.008164 | 0.045577 |
GO:1901564 | organonitrogen compound metabolic process | 17.93% (33/184) | 0.6 | 0.009919 | 0.045667 |
GO:1901137 | carbohydrate derivative biosynthetic process | 2.17% (4/184) | 2.25 | 0.01041 | 0.047012 |
GO:0008150 | biological_process | 45.65% (84/184) | 0.3 | 0.010408 | 0.047305 |
GO:0001522 | pseudouridine synthesis | 1.09% (2/184) | 3.7 | 0.010365 | 0.047412 |
GO:0006633 | fatty acid biosynthetic process | 1.63% (3/184) | 2.84 | 0.008684 | 0.048102 |